Hyperscale Data, Inc. (GPUS): Nasdaq/NYSE listing notice — Hyperscale Data faces NYSE American delisting over low equity; sells additional $1.9M preferred to affiliate

Hyperscale Data, Inc.

NYSE American notified Hyperscale that $2.2M equity fails $6M minimum under Section 1003(a)(ii)/(iii).
Company must submit compliance plan by Jan 17, 2025 and regain compliance by June 18, 2026 or face delisting.
On Dec 20, 2024, sold 1,900 shares of Series C convertible preferred and warrants to affiliate Ault & Company for $1.9M.
Total purchases under agreement now $50M out of $75M available; Series C securities are unregistered.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Hyperscale Data, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

Exchange: nyse american
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 1003(a)(ii), 1003(a)(iii)

Exact text from the filing

December 18, 2024, the Company was notified by the NYSE American that due to the Company’s disclosure in its Form 10-Q filed for the fiscal period ended September 30, 2024, which reported stockholders’ equity of approximately $2.2 million, it no longer meets the requirement that it must have no less than $6 million or more in stockholders’ equity pursuant to the listing standard set forth under Section 1003(a)(ii) and (iii) of the NYSE American Company Guide (the “ Listing Standards ”) because the Company has reported losses from continuing operations and/or net losses in five of its most rece

View on SEC.gov

Browse all listing & compliance notices →

Hyperscale Data, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-24-020851

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.